Literature DB >> 7478432

Influence of acetylsalicylic acid and metabolites on DU-145 prostatic cancer cell proliferation.

T C Viljoen1, C H van Aswegen, D J du Plessis.   

Abstract

Conflicting reports have been published on the anti-tumour activities of acetylsalicylic acid in various cancers. Therefore, the effect of acetylsalicylic acid and its major metabolites has been studied on human prostatic carcinoma DU-145 cells. Investigations concentrated on the influence of acetylsalicylic acid, salicylic acid and salicyluric acid, on cell proliferation, DNA- and protein synthesis of DU-145 cells. DNA and protein synthesis determinations were done in vitro by [3H]thymidine and [3H]glycine incorporation, respectively. No effect on cell plating efficiency was observed, however proliferation studies showed that acetylsalicylic acid and salicylic acid inhibited cell growth (10 mM, 100% inhibition). No significant effect on cell proliferation was ascertained with salicyluric acid. Both DNA and protein synthesis were 40% inhibited by 0.1 mM acetylsalicylic acid. This study demonstrates that acetylsalicylic acid exhibits a significant influence on cell growth of prostatic DU-145 cells. These preliminary results may contribute to a better understanding of the anti-tumour capabilities of acetylsalicylic acid.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478432     DOI: 10.1159/000227512

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  2 in total

Review 1.  Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

Authors:  G Aparicio Gallego; S Díaz Prado; P Jiménez Fonseca; R García Campelo; J Cassinello Espinosa; L M Antón Aparicio
Journal:  Clin Transl Oncol       Date:  2007-11       Impact factor: 3.405

Review 2.  Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications.

Authors:  Jens Staal; Rudi Beyaert
Journal:  Cells       Date:  2018-08-29       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.